Differences in presentation and progression between severe FIC1 and BSEP deficiencies-Reference-Cited by-同舟云学术

Differences in presentation and progression between severe FIC1 and BSEP deficiencies

Published:2010-07 Issue:1 Volume:53 Page:170-178
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Pawlikowska Ludmila,Strautnieks Sandra,Jankowska Irena,Czubkowski Piotr,Emerick Karan,Antoniou Anthony,Wanty Catherine,Fischler Bjorn,Jacquemin Emmanuel,Wali Sami,Blanchard Samra,Nielsen Inge-Merete,Bourke Billy,McQuaid Shirley,Lacaille Florence,Byrne Jane A.,van Eerde Albertien M.,Kolho Kaija-Leena,Klomp Leo,Houwen Roderick,Bacchetti Peter,Lobritto Steven,Hupertz Vera,McClean Patricia,Mieli-Vergani Giorgina,Shneider Benjamin,Nemeth Antal,Sokal Etienne,Freimer Nelson B.,Knisely A.S.,Rosenthal Philip,Whitington Peter F.,Pawlowska Joanna,Thompson Richard J.,Bull Laura N.

Publisher

Elsevier BV

Subject

Hepatology

Reference48 articles.

1. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis;Bull;Nat Genet,1998

2. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis;Strautnieks;Nat Genet,1998

3. Low-γGT familial intrahepatic cholestasis;Knisely,2008

4. Familial intrahepatic cholestasis. 1: Studies of localization and function;Ujhazy;Hepatology,2001

5. ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity;Paulusma;Hepatology,2008

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progressive familial intrahepatic cholestasis type 4: a case report;Journal of Medical Case Reports;2024-09-07

2. EASL Clinical Practice Guidelines on genetic cholestatic liver diseases;Journal of Hepatology;2024-08

3. Flipping the script: Advances in understanding how and why P4-ATPases flip lipid across membranes;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-04

4. Editorial: Corticosteroids for severe checkpoint inhibitor‐induced liver injury—Not one size fits all?;Alimentary Pharmacology & Therapeutics;2024-03-10

5. UK guideline on the transition and management of childhood liver diseases in adulthood;Alimentary Pharmacology & Therapeutics;2024-02-22